Company intelligence / Profile preview

Justice

Palo Alto, California, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Justice Biosystems is a life science tools company focused on revolutionizing sample preparation for molecular diagnostics. Founded by industry veterans, including former Qiagen CEO Peer Schatz, the company develops automated, high-throughput systems designed to simplify and accelerate the extraction of nucleic acids and other biomarkers. Their flagship Justice platform aims to eliminate bottlenecks in the diagnostic workflow, enabling faster and more accurate testing for infectious diseases and oncology. By integrating advanced fluidics and automation, Justice Biosystems seeks to standardize sample prep across clinical and research settings.

Therapeutic areas: OncologyInfectious Diseases
Modalities: DiagnosticsSample PreparationAutomation
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Justice.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Justice.

Explore the full profile